Investor's Business Daily on MSN
Royalty powerhouse: Ligand and Xoma unite in $739 million deal
Ligand Pharmaceuticals snatched up Xoma Royalty in a deal worth $739 million, the companies said Monday as both biotech ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results